Medical Device Industry Executive Mark Didio Joins Cynosure

January 14, 2021

Cynosure has announced that Mark Didio will join Cynosure’s Executive Leadership Team as the company’s new global General Manager of Surgical. An accomplished leader with more than 20 years of executive leadership experience in the medical aesthetics industry, Didio will help accelerate the growth of Cynosure’s global surgical portfolio—which includes devices like TempSure Surgical, Smartlipo Triplex, Cellulaze, Surgitron Dual EMC 90 and MonaLisa Touch—in response to increased demand in the highly attractive minimally invasive surgical space.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • CGI Digital Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Kentucky Rules Do Not Allow Compounding of Six Peptides Despite HHS Peptide Enforcement Policy
    • AMA Urges HHS to Withdraw Proposal Expanding Access to Certain Unapproved Peptides
    • Health Canada Warns Against Unauthorized Peptides After Bacteria Found in Seized Products
    • Injectable PDGF Enters New Aesthetic Trials for Facial Skin Quality and Infraorbital Hollows